Pricing and reimbursement of orphan drugs: the need for more transparency

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy: 1 policy source
twitter: 3 X users

facebook: 2 Facebook pages
wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 191 Dimensions

Readers on

mendeley: 378 Mendeley

Summary Policy documents X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

The social contract and human rights bases for promoting access to effective, novel, high-priced medicines

Cited by World Health Organization on 31 Aug 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Negotiating prices of drugs for rare diseases

Cited by World Health Organization on 26 Mar 2018

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.